Niu et al. [179] suggest that CD147-Ab would serve as a promising drug for the treatment of HCC by inhibiting metastasis and growth, decreasing the expression of MMP-2 and CD31 and inducing tumor necrosis. The gene discussed is BSG; the disease is hepatocellular carcinoma.